Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Pfizer Outlines Its Supply Strategy

October 02, 2011

John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network.

Managing Business Risks During a Merger or Acquisition

October 02, 2011

Getting the most value out of M&As requires proper upfront legwork.

Inside PIC/S: The Importance of PIC/S in a Globalized World

October 02, 2011

Expanding the organization's mandate will strengthen inspections.

Quality Issues for Multiregional Clinical-Trial Materials

October 02, 2011

The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.

Preparing for the Last War

October 02, 2011

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

Q&A with Rao Tatapudy, Catalent

October 02, 2011

A Q&A with Rao Tatapudy, vice-president of scientific affairs at Catalent, on recent industry trends.

Time is of the Essence

October 02, 2011

Letting contamination build up can cause multiple headaches.

Report from India

October 02, 2011

In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.

Global Health Challenges Spur Vaccine Development

October 02, 2011

Manufacturers fund research and reduce prices to tackle diseases.

Sizing Up the Global Market for Excipients

October 02, 2011

The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.